South Africa to start COVID-19 vaccinations with doses from U.S.-based Johnson & Johnson
By Reuters South Africa will start its immunization campaign with Johnson & Johnson’s COVID-19 vaccine after data showed AstraZeneca’s shot offered minimal protection against mild-to-moderate illness from the dominant local virus variant. The country, which has recorded the most coronavirus infections in Africa and more than 46,000 deaths, had planned to start offering healthcare workers the…